<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Retained intracytoplasmic nanoformulations consisting of a hydrophobic and lipophilic modified dolutegravir prodrug encapsulated into poloxamer released the drug from macrophages and suppressed viral replication and spread of virus to CD4
 <sup>+</sup> T cells, while the drug blood and tissue levels in BALB/cJ mice were above 64 ng/mL corresponding to IC
 <sub>90</sub> value for 56 and 28 days, respectively (Sillman et al. 
 <xref ref-type="bibr" rid="CR201">2018</xref>).
</p>
